Houston's life sciences profile was elevated by the first phase of TMC's Helix Park and Eli Lilly's $6.5B biomanufacturing investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results